References
- Aungst, B.J., Nguyen, N.H., Rogers, N.J., Rowe, S.M., Hussain, M.A., White, S.J., Shum, L., 1997. Amphiphilic vehicles improve the oral bioavailability of a poorly soluble HIV protease inhibitor at high doses. Int. J. Pharm., 156, 79-88. https://doi.org/10.1016/S0378-5173(97)00189-0
- Beckmann, W., Otto, W.H., 1996. Occurrence, stability, kinetics of crystallization and polymorphic transition of the A, B and C modification of Abecarnil: Influence of Supersaturation, Temperature, Solvents and Impurities. Chem. Eng. Res. Des., Part A, 74, 750-758.
- Byrn, S., Pfeiffer, R., Ganey, M.; Hoiberg, C., Poochikian., G., 1995. Pharmaceutical Solids: A Strategic Approach to Regulatory Considerations. Pharm. Res., 12, 945-954. https://doi.org/10.1023/A:1016241927429
- Byrn, S., Pfeiffer, R., Stowell, J., 1999. Solid-state chemistry of drugs, 2nd Ed., SSCI, Inc., West Lafayette, pp. 261-278.
- Cole E.T., Cade D., Benameur H., 2008. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration. Adv. Drug Del. Rev 60, 747-756. https://doi.org/10.1016/j.addr.2007.09.009
- Curatolo, W., 1998. Physical chemical properties of oral drug candidates in the discovery and exploratory development settings. Pharm. Sci. Technol. Today., 1(9) 387-393. https://doi.org/10.1016/S1461-5347(98)00097-2
- Hauss D.J. 2007. Oral lipid-based formulations. Adv. Drug Del. Rev., 59, 667-676. https://doi.org/10.1016/j.addr.2007.05.006
- Horter, D., Dressman, J.B., 1997. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv. Drug. Del. Rev., 25, 3-14. https://doi.org/10.1016/S0169-409X(96)00487-5
- Jeong, Y.-N., Seo, M.-K., Lee, S.-H., Choi, Y.-J., Kim, I.-C., Lee, Y.-H., 1996. Pharmacokinetics of the irreversible HIV-1 protease inhibitor, LB71350, in rats and dogs. Pharm. Res., 13, S-486.
- Jeong, Y.-N., Seo, M.-K., Choi, Y.-J., Kim, I.-C., Lee, Y.-H., 1997. High-performance liquid chromatographic assay of a new HIV-1 protease inhibitor, LB71350, in the plasma of dogs. J. Chromatogr. Biomed. Sci. Appl., 703, 284-288. https://doi.org/10.1016/S0378-4347(97)00395-2
- Joshi, H.N., Tejwani, R.W., Davidovich, M., Sahasrabudhe, V.P., Jemal, M., Bathala, M.S., Varia, S.A. and Serajuddin, A.T.M. 2004. Bioavailability enhancement of a pooly water -soluble drug by solid dispersion in polyethylene glycol-polysorbate 80 mixture. Int. J. Pharm. 269, 251-258 https://doi.org/10.1016/j.ijpharm.2003.09.002
- Lee, H.-K., Cho, H., Han, H.-K., 2010. Improved dissolution of poorly water soluble TD49, a novel algicidal agent, via the preparation of solid dispersion. J. Pharm. Invest. 40(3), 181-185. https://doi.org/10.4333/KPS.2010.40.3.181
- Leuner, C., Dressman, J., 2000. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm., 50, 47-60. https://doi.org/10.1016/S0939-6411(00)00076-X
- Lipinski, C.A., 2000. Drug-like properties and the cause of poor solubility and poor permeabiloity. J. Pharmacol. Toxicol. Methods, 44, 235-249. https://doi.org/10.1016/S1056-8719(00)00107-6
- Saleki-Gehardt, A., Ahlneck, C., Zografi, G., 1994. Assessment of disorder in crystalline solids. Int. J. Pharm., 101, 237-247. https://doi.org/10.1016/0378-5173(94)90219-4
- Serajuddin, A.T.M., Sheen, P.-C., Mufson, D., Bernstein, D.F., Augustine, M.A., 1988. Effect of vehicle amphiphilicity on the dissolution and bioavailability of a poorly water-soluble drug from solid dispersions. J. Pharm. Sci., 77, 414-417. https://doi.org/10.1002/jps.2600770512
- Strickley R.G. 2004. Solubilizing excipients in oral and injectible formulations. Pharm. Res. 21(2) 201-230. https://doi.org/10.1023/B:PHAM.0000016235.32639.23
- Stegemann, S., Leveiller, F. Franchi, D., de Jong H., Linden, H., 2007. When poor solubility becomes an issue: From early stage to proof of concept. Eur. J. Pharm. Sci. 31, 249-261. https://doi.org/10.1016/j.ejps.2007.05.110
- Sugimoto, M., Okagaki, T., Narisawa, S., Koida, Y., Nakajima, K., 1998. Improvement of dissolution characteristics and bioavailability of poorly water-soluble drugs by novel cogrinding method using water-soluble polymer. Int. J. Pharm., 160, 11-19. https://doi.org/10.1016/S0378-5173(97)00293-7
- Suryanarayanan, R., 1995. Physical Chracterization of Pharmaceutical Solids, 2nd Ed.: Brittain, H.G. (Ed.), Drugs and the pharmaceutical sciences, Vol. 70, Dekker, New York, pp. 187-221.
- Vasconcelos, T., Sarmento B., Costa P., Solid dispersion as strategy to improve orall bioavailability of poor water soluble drugs. 2007. Drug Discovery Today, 12 (23/24) 1068-1075. https://doi.org/10.1016/j.drudis.2007.09.005
- Waynforth, H.B., 1995. Laboratory animals: An introduction for experimenters, 2nd Ed: Tuffery, A.A. (Ed.), Wiley, New York, pp. 304-306.
- Yamada, T., Saito, N., Anraku, M., Imai, T., Otagiri, M., 2000. Physicochemical Characterization of a new crystal form and improvements in the pharmaceutical properties of the poorly water-soluble antiosteoporosis drug 3,9-bis(N,N-dimethylcarbamoy-loxy)-5H-benzofuro[3,2-c]quinoline-6-one (KCA-098) by solid dispersion with hydroxypropylcelluose. Pharm. Dev. Technol., 5, 443-454. https://doi.org/10.1081/PDT-100102028